Table 7.
Characteristics | Severity and prevalence of potential DDI (%) |
|||||
---|---|---|---|---|---|---|
Contraindication | Major | Moderate | Minor | χ2 | P | |
Age group | ||||||
<30 | 0 (0.0) | 13.3 (18) | 66.7 (27.0) | 20 (3.0) | 1.562 | 0.1 |
31-40 | 0 (0.0) | 18 (37.50) | 27 (56.30) | 3 (6.30) | ||
41-50 | 0 (0.0) | 8 (57.10) | 6 (42.90) | 0 (0.0) | ||
51-60 | 0 (0.0) | 7 (15.60) | 34 (75.6) | 4 (8.90) | ||
>60 | 1 (1.0) | 25 (24.0) | 71 (68.30) | 7 (6.70) | ||
Gender | ||||||
Female | 0 (0.0) | 33 (27.3) | 78 (64.5) | 10 (8.3) | 1.436 | 0.697 |
Male | 1 (1.0) | 27 (25.7) | 70 (66.7) | 7 (6.7) | ||
Ethnicity | ||||||
Igbo | 0 (0.0) | 20 (27.8) | 45 (62.5) | 7 (9.7) | 3.339 | 0.765 |
Yoruba | 0 (0.0) | 23 (26.7) | 57 (66.3) | 5 (5.8) | ||
Others | 1 (1.4) | 17 (24.6) | 46 (66.7) | 5 (7.2) | ||
Education | ||||||
Primary | 0 (0.0) | 1 (7.7) | 11 (84.6) | 1 (7.7) | 4.929 | 0.553 |
Secondary | 0 (0.0) | 40 (28.4) | 91 (64.50) | 10 (7.10) | ||
Tertiary | 1 (1.40) | 19 (26.40) | 46 (63.90) | 6 (8.30) |
Age, gender, ethnicity, and level of education were not significantly associated with the severity of DDI in patients admitted with renal dysfunction. DDI – Drug–drug interaction; EER – Exposure/exposed ratio